Ifp Advisors, Inc Atara Biotherapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.05 Billion
Q4 2023

A detailed history of Ifp Advisors, Inc transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 4,500 shares of ATRA stock, worth $34,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,500

Previous 3,400 32.35%

Holding current value

$34,695

Previous $5,000 60.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	BUY	$0.23 - $1.74 $253 - $1,914	1,100 Added 32.35%	4,500 $2,000
Q3 2023 Oct 12, 2023	BUY	$1.41 - $2.31 $1,410 - $2,310	1,000 Added 41.67%	3,400 $5,000
Q3 2022 Nov 08, 2022	BUY	$2.85 - $8.73 $2,565 - $7,857	900 Added 60.0%	2,400 $120,000
Q2 2022 Sep 06, 2022	BUY	$4.69 - $9.84 $7,035 - $14,760	1,500 New	1,500 $75,000
Q2 2022 Aug 12, 2022	SELL	$4.69 - $9.84 $7,035 - $14,760	-1,500 Closed	0 $0

Q1 2022 Sep 06, 2022	BUY	$8.44 - $16.89 $8,440 - $16,890	1,000 Added 200.0%	1,500 $13,000
Q1 2022 Aug 08, 2022	BUY	$8.44 - $16.89 $4,220 - $8,445	500 New	500 $4,000
Q4 2021 Jan 12, 2022	SELL	$14.7 - $19.89 $11,025 - $14,917	-750 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$11.99 - $17.9 $1,798 - $2,685	150 Added 25.0%	750 $13,000
Q1 2021 Apr 30, 2021	BUY	$14.0 - $20.72 $8,400 - $12,432	600 New	600 $9,000
Q4 2020 Jan 25, 2021	SELL	$12.67 - $26.23 $9,109 - $18,859	-719 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$11.92 - $15.87 $3,802 - $5,062	319 Added 79.75%	719 $9,000
Q2 2020 Aug 05, 2020	BUY	$7.53 - $14.93 $1,506 - $2,986	200 Added 100.0%	400 $6,000
Q3 2019 Nov 07, 2019	BUY	$12.03 - $19.94 $2,406 - $3,988	200 New	200 $3,000
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $482 - $709	-17 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$35.15 - $51.45 $246 - $360	7 Added 70.0%	17 $0
Q1 2018 Jun 03, 2019	SELL	$18.0 - $48.35 $126 - $338	-7 Reduced 41.18%	10 $0
Q1 2018 May 09, 2018	BUY	$18.0 - $48.35 $126 - $338	7 Added 70.0%	17 $0
Q4 2016 Jun 03, 2019	BUY	N/A	10	10 $0

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account